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RESUMO
Introdução: Estudos têm identificado níveis séricos ele-
vados de homocisteína (Hcy) e cisteína (Cys) como fatores
de risco para doenças cardiovasculares, importante causa de
morte em todo o mundo. Fatores associados com elevados
níveis desse marcadores bioquímicos em adultos parecem
bem conhecidos, no entanto na faixa etária pediátrica, dados
sobre essas associações são escassos.
Objetivo: identificar os fatores associados às diferentes
concentrações séricas de homocisteína (hcy) e cisteína (cys)
em crianças e adolescentes. Métodos: trata-se de um estudo
transversal incluindo 483 indivíduos de 7 a 15 anos, ambos
os sexos, de Mutuípe, Bahia. Níveis séricos de Hcy e Cys fo-
ram as variáveis desfecho, e condições sóciodemográficas,
clínicas, bioquímicas e de estilo de vida foram incluídas como
variáveis independentes. Utilizou-se a regressão logística po-
litômica para avaliar a associação entre diferentes níveis de
hcy e cys e variáveis de interesse, usando a razão de preva-
lência (RP) como medida de associação.
Resultados: elevados níveis séricos de Hcy associaram-se
ao sexo masculino (RP=3.74; p<0.01), idade ≥12 anos
(RP=2.56; p<0.01), sobrepeso (RP=2.32; p=0.02), pressão
arterial aumentada (RP=1.97; p<0.01), baixos níveis de
HDL-c (RP=1.21; p=0.03), hipertrigliceridemia (RP=1.62;
p=0.03) e baixo consumo de alimentos protetores (RP=1.46;
p=0.02). Para a Cys, seus níveis aumentados associaram-se
à idade ≥12 anos (RP=2.1; p=0.03), sobrepeso (RP=2.52;
p=0.03); pressão arterial aumentada (PR=1.28; p=0.03),
baixos níveis de HDL-c (RP=1.15; p=0.01), hipertrigliceride-
mia (RP=1.41; p=0.02) e baixo consumo de alimentos pro-
tetores (RP=1.46; p=0.01).
Conclusões: idade ≥12 anos, sobrepeso, pressão arterial
aumentada, baixos valores de HDL-c, hipertrigliceridemia e
baixo consumo de alimentos protetores associaram-se aos
níveis séricos elevados tanto de Hcy, quanto de Cys, com ex-
ceção do sexo masculino, que se associou apenas à hiperho-
mocisteinemia. Considerando que esses fatores têm apre-
sentado ocorrência crescente na infância e adolescência, a
prevenção e controle de níveis elevados de Hcy e Cys deve
ser adotada, prevenindo doenças crônicas não transmissíveis
nesse estágio da vida.
PALAVRAS CHAVES
Homocisteína, cisteína, fatores associados, crianças, ado-
lescentes
ABSTRACT
Introduction: Studies have identified high serum homo-
cysteine (Hcy) and cysteine (Cys) levels as risk factor for car-
diovascular diseases, important cause of death in all world.
The factors associated with high levels of these biochemistry
markers in adults are well known; however, data are sparse
on these associations in the pediatric age group.
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Objective: the objective was to identify factors associated
with different concentrations of serum Hcy and Cys in children
and adolescents.
Methods: a cross-sectional study with 483 individuals of 7-
15 years of age of both sexes, from a municipality of Bahia.
Serum Hcy and Cys levels were considered outcome vari-
ables, with exposure being evaluated according to sociode-
mographic, clinical, biochemical and lifestyle variables.
Polytomous logistic regression was used to evaluate the asso-
ciation between exposure and outcome.
Results: high serum Hcy levels were associated with being
male (PR=3.74; p<0.01), age ≥12 years (PR=2.56; p<0.01),
being overweight (PR=2.32; p=0.02), high blood pressure
(PR=1.97; p<0.01), low HDL-c levels (PR=1.21; p=0.03),
high triglyceride levels (PR=1.62; p=0.03) and poor intake of
foods that protect against hyperhomocysteinemia (PR=1.46;
p=0.02). High serum Cys levels were associated with age ≥12
years (PR=2.1; p=0.03), being overweight (PR=2.52;
p=0.03); high blood pressure (PR=1.28; p=0.03), low HDL-c
levels (PR=1.15; p=0.01), high triglyceride levels (PR=1.41;
p=0.02) and poor intake of foods that protect against hyper-
cysteinemia (PR=1.46; p=0.01).
Conclusions: age >12 years, being overweight, high
blood pressure, low HDL-c levels, high triglyceride levels and
poor intake of protective foods are common factors found in
individuals with increased serum Hcy and Cys levels. Being
male was associated with high serum Hcy levels alone.
Considering that these factors are already present early in
life, measures should be adopted to prevent and control high
Hcy and Cys levels, promoting health and preventing chronic
non-communicable diseases at this stage of life.
KEY WORDS
Homocysteine, cysteine, associated factors, children, ado-
lescents
ABBREVIATIONS
FFQ: food frequency questionnaire.
HPLC: high performance liquid chromatography.
HCY: homocysteine.
CYS: cysteine.
INTRODUCTION
Studies have identified high serum homocysteine levels as
a risk factor for cardiovascular disease1-3, an important cause
of death in all world4. The mechanism underlying cardiovas-
cular disease involves the proliferation of vascular smooth
muscle, and endothelial dysfunction and damage5.
A meta-analysis of prospective studies involving popula-
tions with no diagnosis of cardiovascular disease at baseline
found that for every 5 µmol/L increase in homocysteine lev-
els there was a 20% increased risk of cardiac events irrespec-
tive of the traditional risk factors for these diseases3.
A recent study conducted with 13,247 individuals from two
US cohorts reported that adding homocysteine levels to the
traditional Framingham risk score to predict cardiovascular
events significantly improved prediction, particularly in indi-
viduals for whom the risk of cardiovascular disease was inter-
mediate6. This finding reinforced data from other studies on
the association between homocysteine and cardiac disease.
Between 5 and 10% of the adult population worldwide
have high homocysteine levels7. Data for other population
groups are sparse. In Brazil, hyperhomocysteinemia was
identified in 19.4% of children and adolescents in the city of
São Paulo, with a higher prevalence being found in boys8.
Although the chemical structure and metabolic behavior of
serum cysteine and homocysteine are similar, a potential as-
sociation between cysteine and cardiovascular events has re-
ceived little attention from investigators9. Nevertheless, the
few data available suggest similar associations between both
biochemical parameters and cardiovascular disease9-11.
Despite the lack of an established cut-off point for cysteine
in children and adolescents, a study conducted in São Paulo,
in which the classification of the 90th percentile of the sam-
ple was used, reported high serum cysteine levels in 9.6% of
boys and 9.0% of girls12.
Although the factors associated with high serum homocys-
teine and cysteine levels in the adult population are already
known, few studies have evaluated these associations in the
pediatric age group.
OBJECTIVE
The objective of the present study was to identify the fac-
tors associated with high serum homocysteine and cysteine
levels in children and adolescents.
METHODS
Sample and study design
This was a cross-sectional study including schoolchildren
from Mutuípe-Bahia, Brazil. Bood samples were collected from
540 children. Thirty-seven of these children could not be
traced, while in an additional 15 cases, the serum was insuf-
ficient for measurement and 5 were lost during homocysteine
and cysteine analysis. Therefore, this study consisted of 483
boys and girls of 7 to 15 years of age, selected at random
from a list of elementary schoolchildren registered with the
Mutuípe Municipal Education Department in 2006.
Consequently, this study sample has a power of 93% and
94% to identify a 10% prevalence rate of high serum levels
of homocysteine and cysteine, respectively, taking as a refer-
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ence the prevalence rates of hyperhomocysteinemia and of
high serum cysteine levels reported for children in São
Paulo12.
Exclusion Criteria
The exclusion criteria consisted of actors that could affect
homocysteine or cysteine levels such as the use of medication
(anticonvulsants, diuretics, thiazides and corticoids) and the
presence of conditions such as diabetes mellitus, chronic re-
nal failure, liver disease or hyperthyroidism13. Pregnancy,
breastfeeding and any physical handicaps that would prevent
an anthropometric evaluation from taking place also consti-
tuted exclusion criteria. Nevertheless, none of the children
had any of these conditions.
METHODS
Sociodemographic and lifestyle-related data
The sociodemographic data consisted of the number of
rooms in the house and the number of individuals living in it,
the principal form of lighting and the occupation of the head
of the family. These data were used to calculate a socioeco-
nomic index. Data were collected on water supply to the
home, the source of drinking water and how garbage and
household waste are disposed, with these data being used to
calculate the environmental index. The answers to these vari-
ables were awarded scores that ranged from 0 to 4, with 0
representing the poorest conditions and 4 the best.
Maternal education was evaluated separately, given that
this factor is also associated with the cultural and dietary as-
pects of the society in which the individual lives.
Physical activity level was evaluated using a structured
questionnaire on the frequency with which physical activity
was performed, excluding the once-a-week exercise that is
part of the school curriculum. Another lifestyle-related vari-
able included in the study was alcohol consumption.
Family history of a chronic non-communicable
disease
The student and/or his/her parent or guardian provided in-
formation on any chronic, non-communicable diseases in the
family and, if present, the student’s relationship to that indi-
vidual was recorded.
Anthropometric data: weight, height and waist
circumference
Anthropometric status was evaluated according to body
mass index for age (BMI/age) and sex, and by excess abdom-
inal fat. Weight and height were measured as defined by
Lohman14, and waist circumference were measured according
to the World Health Organization (WHO)15.
The recommendations of the WHO for individuals of 5-19
years of age were used to classify BMI/age16. Considering that
there is no consensus on the cut-off point of waist circumfer-
ence for the diagnosis of excess abdominal fat in children and
adolescents, the value of the 90th percentile of the study sam-
ple was adopted as recommended by Freedman et al.17.
Arterial blood pressure
Blood pressure was measured and classified in accordance
with the VI Brazilian Guidelines on Arterial Hypertension and
the levels were classified according to height, age and sex,
adopting the 90th percentile as the cut-off point18.
Dietary Intake
Dietary intake was evaluated using a food frequency ques-
tionnaire (FFQ), which was adapted from an instrument that
had previously been used in children and adolescents in the
same town19.
The data obtained were treated in accordance with a score
methodology20. The overall dietary intake of each food item
was converted into scores by multiplying the weekly fre-
quency of intake by 4 (the number of weeks in a month) and
dividing it by 30 (the number of days in a month), thus arriv-
ing at a mean daily intake score, which were then classified
into tertiles.
After these scores were calculated, two dietary groups
were constructed:
a) Group of food items that increase the risk of high serum
homocysteine and cysteine levels: food items poor in complex
B vitamins, as not whole grains, pasta, cookies, candies, pas-
try, fries, vegetable oils.
b) Group of food items that protect against high serum ho-
mocysteine and cysteine levels, including food items that are
sources of fiber, complex B vitamins and minerals (meats,
fish, dark green vegetables, whole and enriched grain prod-
ucts, legumes and citrus fruits).
Biochemical tests
Blood samples were collected in the morning after at least
12 hours of fasting. A 10-ml sample was collected by venous
puncture into a sterile, disposable Vacutainer (BD®) with no
anticoagulant. Immediately after collection, the blood was
centrifuged at 3000 rpm for 5 minutes. Aliquots of serum
were stored in previously demineralized Eppendorf tubes at -
20oC. Total cholesterol (TC), HDL-c, triglyceride and glucose
levels were measured using an enzymatic method. LDL cho-
lesterol (LDL-c) levels were calculated according to the
Friedewald equation21.
Serum homocysteine and cysteine levels were measured at
the Inborn Errors of Metabolism Laboratory of the Federal
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University of São Paulo by high performance liquid chro-
matography (HPLC) with isocratic elution and fluorometric de-
tection, considered the gold-standard methodology for this
procedure22. Briefly, the measurement process involved the
following steps: reduction (to reduce and release the protein-
bound thiols), precipitation of the proteins, and derivatization,
according to the methodology proposed by Pfeiffer, Huff and
Gunter (1999)23.
Classification of the biochemical variables
Glucose: Glucose levels were classified according to the cri-
teria established by the Brazilian Diabetes Society (glycemia
≥ 126mg/dl)24.
Lipid profile: The cut-off points suggested by Jolliffe and
Janssen (2006)25 for adolescents of 12-19 years of age, which
take into account the variations in lipid profile according to
age and sex, were adopted. For schoolchildren under 12 years
of age, the recommendation of the National Health and
Nutrition Examination Survey (NHANES)) was used to classify
HDL-c, while the definitions proposed by the National
Cholesterol Education Program (NCEP) were used to classify
total cholesterol, LDL-c and triglycerides. These cut-off points
were adopted based on the results of studies showing that
the use of these classification resulted in the highest accuracy
for classifying the risk of adolescents developing dyslipidemia
as adults26,27.
Identification of variables
The outcome variables consisted of serum homocysteine
(Hcy) and cysteine (Cys) levels, which were classified into
quintiles. The covariables included were age, sex, maternal
education, environmental index, socioeconomic index, blood
pressure, glucose, total cholesterol, LDL-c, HDL-c, triglyc-
erides, BMI/age, practice of physical activity, family history of
chronic non-communicable diseases, intake of foods that pro-
tect against hyperhomocysteinemia and hypercysteinemia, in-
take of foods that increase the risk of hyperhomocysteinemia
and hypercysteinemia and alcohol consumption.
Statistical Analysis
Means and standard deviations were used to describe the
continuous variables. Levels of Hcy and Cys were compared
in relation to the exposure variables using Student’s t-test for
equal or unequal variances. The variables Hcy and Cys were
submitted to logarithmic transformation, since their distribu-
tion was not normal.
To identify the factors associated with serum Hcy and Cys
levels, polytomous logistic regression analysis was adopted,
appropriate for outcome variables with more than two cate-
gories28,29. The prevalence ratio (PR) was adopted as the es-
timator28.
A polytomous regression model was constructed for each
outcome variable (serum Hcy and Cys). Initially, a univariate
analysis was performed to select candidate variables for the
multivariate model. For this, a significance level of p< 0.20
was adopted. Those variables that remained in the model at
a statistical significance level of p<0.05 were included in the
final model.
The goodness-of-fit of the polytomous logistic regression
model was assessed for each individual model using the 1st
quintile of Hcy and Cys as the reference level. For this test,
non-significant p-values were adopted as indicators of the
goodness-of-fit of the model28.
The analyses were performed using the Stata/IC statistical
software package for Mac, version 12.0 (StataCorp, College
Station, TX, USA).
Ethical Aspects
The study protocol was submitted to the internal review
board of the School of Nutrition, Federal University of Bahia,
and approved under reference number 03/06.
The child’s participation in the study required authorization
from his/her parents and/or guardians. After being duly in-
formed with respect to the study objectives and agreeing to
the inclusion of the child in the study, the parents and/or
guardians signed an informed consent form.
RESULTS
Serum Hcy levels varied according to sex, with a mean of
7.1 ± 1.88 µmol/L for the girls and 7.7 ± 1.88 µmol/L for the
boys. The same did not apply to Cys levels. Furthermore,
mean Hcy levels increased with age in both boys and girls,
with mean levels being higher in the boys than in the girls at
all ages (Table 1). In the case of Cys, an increase in mean val-
ues was found from 10 years of age onwards, following the
same trend irrespective of sex.
The results showed in Table 2 identified that in the case of
girls under 10 years of age with low HDL-c levels, serum Hcy
levels were higher than those found in girls of the same age
with normal levels of this lipoprotein. No associations were
found between mean Hcy levels and any of the other vari-
ables in the girls, irrespective of age.
With respect to the boys, mean Hcy levels were higher in
those who were overweight compared to those of normal
weight at all the ages investigated. It was also found that in
the boys of 12 years of age or more mean Hcy levels were
higher in those with an above-normal waist circumference,
low HDL-c levels and high blood pressure. In those under 10
years of age mean Hcy levels were higher when serum
triglyceride levels were also high. No associations were
found between mean Hcy levels and any of the other vari-
ables in boys (Table 2).
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Considering results showed in Table 3, in girls under 10
years of age, higher mean Cys levels were found in the over-
weight girls. For those over 12 years of age, mean Cys levels
were higher in those with a larger waist circumference and
with high blood pressure. No associations were found be-
tween mean Cys levels and any of the other variables in girls.
No associations were found between Cys levels according to
age and sex, and total cholesterol, LDL-c or glucose levels.
In the case of boys over 12 years of age, mean serum cys-
teine levels were higher in those with lower HDL-c levels and
high triglyceride levels. No statistically significant associations
were found with any of the other variables (Table 3).
Table 4 shows the results of the polytomous logistic regres-
sion models. With the exception of being male, which was
found to be a risk factor for high serum Hcy levels in the dif-
ferent quintiles of distribution, the other risk factors evaluated
were only associated with the highest category of Hcy level
(the 5th quintile: >8.6 µmol).
According to these results, a 3.74 times higher prevalence
of serum Hcy levels > 8.6 µmol/L was found in boys com-
pared with the prevalence in the girls. The prevalence of high
serum Hcy levels was 2.56 times greater in children over 12
years of age compared to the children less than 12 years of
age. In overweight individuals, the prevalence of hyperhomo-
cysteinemia was 2.32 times greater compared to individuals
of normal weight. Additionally, in children and adolescents
with high blood pressure, high triglyceride levels, low HDL-c
levels and whose intake of protective foods was poor, there
was a 97%, 62%, 21% and 46% greater prevalence of hy-
perhomocysteinemia, respectively, compared to the preva-
lence rates in individuals without these risk factors (Table 4).
With respect to serum Cys levels, an association was found
with the exposure factors only in the 5th quintile of distribution
of this variable (>463.4 µmol). Therefore, the prevalence of
high Cys levels was 2.1 times greater in schoolchildren over 12
years of age compared to younger children, while the preva-
lence of hypercysteinemia was 2.52 times greater in over-
weight children compared to those of normal weight. In addi-
tion, it was found that individuals with high blood pressure,
hypertriglyceridemia, low HDL-c levels and poor intake of pro-
tective foods had prevalence rates of hypercysteinemia that
were 28%, 41%, 15% and 46% higher, respectively, than
those found in individuals without these risk factors (Table 4).
DISCUSSION
In the present study, being over 12 years of age, having a
poor intake of protective foods, being overweight, having high
blood pressure, low HDL-c levels and high triglyceride levels
were common factors present in individuals with high serum
Hcy and Cys levels. Being male was associated with high
serum Hcy levels alone and as these levels increased from the
3rd to the 5th quintile of distribution, the prevalence ratio also
increased, indicating a greater susceptibility to hyperhomo-
cysteinemia in males.
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Table 1. Mean serum homocysteine and cysteine levels according to sex and age. Mutuípe, Bahia, Brazil, 2006.
N=483.
* t-test for comparison of means with unequal variance.
** t-test for comparison of means with equal variance.
Age
Serum homocysteine levels (Mean/SD;µmol/L)
Girls Boys Total p-value*
- <10 years 6.6 / 1.43 7.4 / 1.82 6.9 / 1.63 <0.01
- 10-12 years 7.0 / 1.76g 7.5 / 1.44 7.2 / 1.64 0.02
- >12 years 7.5 / 2.12 8.0 / 2.16 7.7 / 2.15 0.02
Total 7.1 / 1.88 7.7 / 1.88 7.3 / 1.90 <0.01
Age
Serum cysteine levels (Mean / SD; µmol/L)
Girls Boys Total p-value**
- <10 years 396.4 / 62.9 393.1 / 62.7 395.1 / 62.6 > 0.38
- 10-12 years 402.7 / 69.8 414.3 / 59.9 407.8 / 65.6 0.03
- >12 years 406.5 / 66.3 419.5 / 65.9 409.3 / 65.9 0.03
Total 406.8 / 66.7 410.4 / 63.8 408.3 / 65.5 > 0.05
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Table 2. Mean serum levels of homocysteine by sex and age, according to anthropometric status, lipid profile, glucose levels and blood
pressure. Mutuípe, Bahia, Brazil, 2006.
N=483.
* p < 0.05t-test for comparison of means with equal variance.
** p < 0.05 t-test for comparison of means with unequal variance.
Serum levels of homocysteine (Mean/SD; µmol/L)
Girls Boys
<10 years 10-12 years >12 years <10 years 10-12 years >12 years
BMI/Age
-Normal weight 6.55 /1.34 6.93/ 1.80 7.47/ 2.27 7.14/ 1.66* 7.53/ 1.50* 8.10/ 2.47*
- Overweight 6.96 / 2.00 7.45/ 1.70 7.99/ 1.59 8.67/ 2.33 8.75/ 1.84 9.15/ 2.03
WC
- <P90 6.55/ 1.43 6.95/ 1.76 7.56/ 2.23 7.47/ 1.91 7.65/ 1.50 7.56/ 1.95*
- ≥P90 7.23/ 1.44 7.54/ 1.80 7.64/ 1.90 7.21/ 1.88 7.37/ 1.93 8.59/ 2.77
Total cholesterol
- Within normal range 6.65/ 1.47 7.16/ 1.75 7.64/ 2.18 7.51/ 1.90 7.62/ 1.59 8.39/ 2.64
- High 6.45/ 1.33 6.70/ 1.91 6.76/ 1.61 7.19/ 1.95 7.55/ 1.42 7.42/ 3.79
LDL-c
- Within normal range 6.56/ 1.42 7.17/ 1.77 7.64/ 2.17 7.49/ 1.93 7.50/ 1.36 7.42/ 2.64
- High 6.86/ 1.53 6.61/ 1.80 6.65/ 1.81 7.32/ 1.83 7.63/ 1.60 8.39/ 3.79
HDL-c
- Within normal range 5.89/1.50** 6.69/ 1.23 7.16/ 1.37 7.16/ 1.50 7.40/ 1.01 7.96/2.53**
- Low 6.75/ 1.40 7.17/ 1.96 7.65/ 2.21 7.64/ 2.01 7.92/ 1.64 8.98/ 3.21
Triglycerides
- Within normal range 6.41/ 1.38 7.05/ 1.77 7.52/ 2.45 7.08/1.60** 7.54/ 1.31 8.33/ 2.97
- High 6.77/ 1.47 7.10/ 1.81 7.65/ 1.74 8.43/ 2.28 7.71/ 1.89 8.41/ 2.13
Glucose
- Within normal range 6.54/ 1.44 6.49/ 1.45 7.05/ 1.38 7.42/ 1.92 7.62/ 1.58 8.15/ 2.43
- High 6.60/ 1.40 7.11/ 1.80 7.62/ 2.20 8.33/ 0.53 7.51/ 1.47 8.39/ 2.68
Blood pressure
- Within normal range 6.48/ 1.37 6.90/ 1.56 7.51/ 2.27 7.36/ 1.93 8.21/ 2.44 7.68/1.45*
- High 6.74/ 1.55 7.32/ 2.24 7.74/ 1.48 7.58/ 2.01 8.33/ 2.47 8.15/ 1.88
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Table 3. Mean serum levels of cysteine by sex and age, according to anthropometric status, lipid profile, glucose levels and blood pres-
sure. Mutuípe, Bahia, Brazil, 2006.
N=483
* p < 0.05t-test for comparison of means with equal variance.
Serum levels of cysteine (Mean / SD; µmol/L)
Girls Boys
<10 years 10-12 years >12 years <10 years 10-12 years >12 years
BMI/Age
-Normal weight 392.7/61.2* 396.6/71.2 413.0/ 63.8 387.7/ 61.7 412.3/ 59.8 414.5/ 61.9
- Overweight 423.5/ 71.8 418.5/64.9 429.9/ 75.0 413.7/ 65.0 422.7/ 62.7 430.9/ 77.4
WC
- <P90 395.2/ 61.2 417.9/ 65.0 396.6/70.3* 391.6/ 64.3 411.5/ 57.8 417.1/ 61.9
- ≥P90 412.0/ 87.7 411.8/ 71.3 426.6/ 64.4 417.4/ 8.03 430.0/ 72.0 423.1/ 79.4
Total cholesterol
- Within normal range 393.3/ 64.8 400.8/ 70.0 420.4/ 66.6 396.7/ 63.4 414.6/ 60.6 420.5/ 65.2
- High 374.8/ 52.2 410.6/ 71.0 397.3/ 48.2 386.4/ 60.2 412.0/ 64.6 414.3/ 58.1
LDL-c
- Within normal range 397.9/ 63.5 400.6/ 69.1 363.9/ 39.3 391.7/ 63.5 410.3/ 58.1 380.3/ 58.2
- High 386.9/ 61.1 412.3/ 74.8 420.2/ 66.3 398.0/ 62.2 435.5/ 68.5 420.5/ 65.2
HDL-c
- Within normal range 398.1/ 56.6 389.9/ 72.3 411.9/ 68.7 388.3/ 62.1 404.1/ 66.0 417.8/58.2*
- Low 400.0/ 92.2 409.6/ 56.9 420.0/ 53.3 403.8/ 71.9 413.1/ 68.9 463.2/ 62.1
Triglycerides
- Within normal range 399.8/ 62.4 402.0/ 72.8 412.5/ 64.9 389.5/ 57.6 392.9/ 48.4 404.1/59.9*
- High 381.2/ 65.3 405.0/ 64.5 417.7/ 67.0 416.4/ 91.7 420.1/ 71.5 440.5/ 57.1
Glucose
- Within normal range 397.4/ 62.2 403.7/ 70.1 405.7/ 80.9 366.5/ 62.6 414.5/ 60.3 405.8/ 66.0
- High 377.1/ 83.8 387.8/ 70.5 417.5/ 65.3 394.1/ 82.8 412.7/ 61.3 419.8/ 67.8
Blood pressure
- Within normal range 391.3/ 58.6 394.5/57.2 404.8/ 60.4* 393.9/ 66.3 414.8/ 64.2 421.4/ 63.8
- High 403.3/ 67.3 412.7/81.7 447.1/ 82.6 387.9/ 67.5 407.4/ 50.5 419.3/ 76.6
Other investigators have also reported higher Hcy levels in
males, both in schoolchildren and in other age groups30,31.
These differences may be explained by a greater efficacy in
the remethylation and transmethylation phases in women,
through mechanisms as yet unknown. These phases repre-
sent important steps in Hcy metabolism and the heightened
efficacy of these steps in women may result in differences be-
tween males and females32, thus explaining the association
identified in the present study.
It is possible that the association between high serum Hcy
and Cys levels and increasing age could be mediated by the
poor intake of sources of micronutrients in adolescents, par-
ticularly the vitamin B complex, which is vital for Hcy and Cys
metabolism. Indeed, vitamin B complex deficiency may inhibit
some physiological steps in the metabolism of these amino
acids. Recently, prevalence rates of a poor dietary intake of
the vitamin B complex that ranged from 7.6% to 22.9% in
males and from 9.5% to 34.2% in females were found for
Brazilian adolescents of 13-19 years of age33. Therefore,
these dietary patterns may also be common in the adoles-
cents evaluated in the present study and may contribute to-
wards explaining the association between high serum levels
of Hcy and Cys and age.
Poor intake of protective foods was positively associated
with high Hcy and Cys levels in the present study. In this sce-
nario of possible poor micronutrient intake, evaluated by the
frequency, a deficiency of pyridoxine, vitamin B12 and folic
acid may inhibit and/or compromise the metabolic pathways
of the remethylation and transsulfuration of methionine, alter-
ing the serum levels of this amino acid32.
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Table 4. Factors associated with high serum homocysteine and cysteine levels in children and adolescents. Mutuípe, Bahia, Brazil,2006.
Sample size: 497.
The reference category for the equation was the 1stquintile(HCY<5.8µmol/L and CYS<352.6µmol/L).
*HCY = serum homocysteine.
†Polytomous logistic regression models; goodness-of-fit p-value not significant.
ŧTriglycerides.
§CYS = serum cysteine.
Variables
HCY* PR (95%CI); p-value†
2nd Quintile
(5.8 - 6.7µmol/L)
3rd Quintile
(6.7- 7.4µmol/L)
4th Quintile
(7.4 - 8.6µmol/L)
5thQuintile
(>8.6µmol/L)
Male 1.65 (0.82-2.32); 0.16 2.46 (1.24-2.88); 0.01 3.68(1.83-4.42);<0.01 3.74 (2.30-4.34);<0.01
Age>12 years 1.30 (0.67-1.71); 0.43 1.19 (0.61-1.72); 0.55 1.51 (0.76-2.01); 0.23 2.56 (1.97-3.14);<0.01
Low intake of protective foods 1.19 (0.82-1.36); 0.58 0.95 (0.50-1.42); 0.89 1.15 (0.791.42); 0.67 1.46 (1.23-1.72); 0.02
Overweight 1.33 (0.67-1.64); 0.40 1.47 (0.74-1.94); 0.26 1.73 (0.84-2.56); 0.13 2.32 (2.11-2.85); 0.02
High blood pressure 1.70 (0.65-2.42); 0.27 2.46 (0.99-3.12); 0.05 1.77 (0.76-1.99); 0.16 1.97 (1.46-2.20);<0.01
High TGŧ 1.15 (0.78-1.26); 0.67 0.94 (0.57-1.27); 0.86 1.09 (0.95-1.53); 0.79 1.62 (1.23-1.98); 0.03
Low HDL-c 0.86 (0.41-1.58); 0.69 0.67 (0.39-1.13); 0.42 0.94 (0.81-1.15); 0.59 1.21 (1.12-1.34); 0.03
Variables
CYS§ PR (95% CI); p-value†
2ndQuintile
(352.6-383.3µmol/L)
3rdQuintile
(383.3-416.2µmol/L)
4thQuintile
(416.2-463.4µmol/L)
5thQuintile
(>463.4µmol/L)
Age>12 years 0.89 (0.46-1.72); 0.73 1.37 (0.69-2.73); 0.36 1.10 (0.55-2.20); 0.77 2.10 (1.79-2.39); 0.03
Low intake of protective foods 1.73 (0.89-1.97); 0.33 1.51 (0.77-1.96); 0.79 1.91 (1.78-2.01); 0.06 1.46 (1.34-1.67); 0.01
Overweight 1.47 (0.59-2.65); 0.39 1.79 (0.74-2.31); 0.19 2.31 (0.97-2.51); 0.06 2.52 (1.60-2.95); 0.03
High blood pressure 1.03 (0.81-1.32); 0.76 1.19 (0.94-1.52); 0.13 1.22 (0.97-1.55); 0.08 1.28 (1.19-1.62); 0.03
High TGŧ 1.01 (0.51-1.94); 0.98 1.20 (0.62-2.32); 0.58 0.95 (0.47-1.91); 0.90 1.41 (1.19-1.88); 0.02
Low HDL-c 0.97 (0.94-1.01); 0.25 0.98 (0.94-1.01); 0.30 0.95 (0.92-1.09); 0.06 1.15 (1.05-1.25); 0.01
Another important epidemiological finding of the present
study concerns the association between high Hcy and Cys
levels and overweight in schoolchildren. These results add
to the finding of the obesogenic role of high Hcy and Cys
levels, giving strength to the recently described theory of a
metabolic role of these parameters in weight gain34. This
theory is supported, principally, by results of experimental
studies showing that high Cys levels stimulate the synthesis
of fatty acids, promoting adiposity. These acids undergo
auto-oxidation in the adipocytes, releasing hydrogen perox-
ide (H2O2), which acts as an inhibitor of lipolysis, stimulat-
ing lipid synthesis and resulting in the activation of lipogen-
esis. Furthermore, the inhibiting effect of high Hcy levels on
lipolysis has been shown in in vitro and in vivo studies con-
ducted by Wang et al. (2011)35. Those investigators re-
ported that high Hcy levels inhibit lipolysis through a mech-
anism that involves activation of the AMP-activated protein
kinase (AMPK), an important sensor of cellular energy level,
which exerts an antilipolytic effect on the adipocytes, en-
couraging fat accumulation.
These results contribute to the body of evidence showing
that, in this age group too, high Hcy and Cys levels are sig-
nificantly associated with weight gain. When the association
between these biochemical parameters and low HDL-c levels
and high triglyceride levels is also taken into consideration,
these findings become even more relevant.
In this respect, Gil-Prieto et al. (2009)36 also identified an
inverse association between serum HDL-c levels and Hcy
values in adolescents. In a cross-sectional study, Anand et
al. (2009)37 identified an association between high Hcy, low
HDL-c and high triglyceride levels. Few studies have been
conducted to evaluate the association between Cys and the
lipid profile of children and adolescents. In a cross-sectional
study conducted with schoolchildren in a Brazilian town,
Pereira da Silva et al. (2013)12 found an association between
Cys and HDL-c.
A possible mechanism underlying the association between
Hcy, Cys and changes in HDL-c may involve the inhibition of
apolipoprotein A-1 gene transcription, with a consequent re-
duction in the synthesis of HDL-c in the liver, leading to ath-
erosclerosis38. Although studies have identified an associa-
tion between Hcy and triglycerides, the mechanisms behind
this association have yet to be clarified. On the other hand,
considering that excess weight is associated with an unde-
sirable lipid profile consisting of low HDL-c and high triglyc-
eride levels, it is possible that the association between these
lipids and Hcy and Cys occurs through the same metabolic
pathways that, directly or indirectly, play a role in determin-
ing excess weight.
In the present study, high blood pressure was also associ-
ated with high serum Hcy and Cys levels. Some epidemiolog-
ical studies have found a weak, albeit significant, association
between Hcy levels and blood pressure in children and ado-
lescents30. Although to the best of our knowledge no studies
have been conducted on the association between Cys and
blood pressure in the pediatric age group, data from the
Hordaland Homocysteine Study for the adult population
showed a strong association between blood pressure and
high Cys levels10.
With respect to this association, studies have shown that
high serum Hcy and Cys levels are related to blood pressure
due to the reaction of these elements with nitric oxide,
forming nitrosothiol, reducing its bioavailability and result-
ing in damage to the endothelium-dependent vasodilation
mediated by nitric oxide39. Experimental studies have also
shown that hyperhomocysteinemia leads to an increase in
the arterial stiffness caused by the destruction of elastin
fibers, increasing collagen production and smooth muscle
cell activity40.
This study involves limitations that are inherent to its cross-
sectional design in which no causal or temporal associations
are established between the variables. Other limitations in-
clude the lack of adjustment of the models for vitamin B com-
plex levels, serum creatinine and MTHFR 677C>T genotype,
which globally contribute to the variation in Hcy in healthy
populations. For this reason, further studies are necessary to
confirm the hypotheses raised here.
CONCLUSIONS
Considering the methodology used, the robust statistical
analysis and the evidence reported by other investigators it
is possible to conclude that high Hcy and Cys levels in chil-
dren and adolescents are associated with a set of factors
that establish an important epidemiological scenario of
morbidities from chronic non-communicable diseases, in-
cluding overweight, high blood pressure, low HDL-c and
high triglyceride levels. Considering that these factors are
already present early in life, measures should be adopted to
prevent and control high Hcy and Cys levels to promote
health and prevent chronic non-communicable diseases at
this stage of life.
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